Carbocisteine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB04339 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 49 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gout | KG + DL |
| 2 | bronchitis | KG + DL |
| 3 | appendicitis | KG + DL |
| 4 | congestive heart failure | KG + DL |
| 5 | acute pulmonary heart disease | KG + DL |
| 6 | epiglottitis | KG + DL |
| 7 | peritonitis | KG + DL |
| 8 | laryngitis | KG + DL |
| 9 | Lesch-Nyhan syndrome | KG + DL |
| 10 | gastrointestinal allergy | KG + DL |
| 11 | chronic kidney disease | KG + DL |
| 12 | rheumatoid arthritis | KG + DL |
| 13 | obsolete hyperuricemia (disease) | KG + DL |
| 14 | end stage renal failure | KG + DL |
| 15 | urinary tract infection (disease) | KG + DL |
| 16 | Ureaplasma urethritis | KG + DL |
| 17 | gonococcal urethritis | KG + DL |
| 18 | uterine inflammatory disease | KG + DL |
| 19 | endometriosis of pelvic peritoneum | KG + DL |
| 20 | xanthogranulomatous pyelonephritis | KG + DL |
| 21 | middle ear cholesterol granuloma | KG + DL |
| 22 | infectious otitis media | KG + DL |
| 23 | laryngotracheitis | KG + DL |
| 24 | allergic otitis media | KG + DL |
| 25 | otosalpingitis | KG + DL |
| 26 | ulcerative proctosigmoiditis | KG + DL |
| 27 | brachydactyly-syndactyly syndrome | KG + DL |
| 28 | middle ear disease | KG + DL |
| 29 | chronic otitis media | KG + DL |
| 30 | non-suppurative otitis media | KG + DL |
| 31 | suppurative otitis media | KG + DL |
| 32 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 33 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 34 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 35 | anthracosis | KG + DL |
| 36 | osteoarthritis | KG + DL |
| 37 | diabetic nephropathy | KG + DL |
| 38 | gastroduodenitis | KG + DL |
| 39 | hyperplastic polyp | KG + DL |
| 40 | pseudoachondroplasia | KG + DL |
| 41 | high output heart failure | KG + DL |
| 42 | osteoarthritis susceptibility | KG + DL |
| 43 | gastrointestinal polyp | KG + DL |
| 44 | symptomatic heart failure | KG + DL |
| 45 | heart failure | KG + DL |
| 46 | cholecystolithiasis | KG + DL |
| 47 | hypouricemia, renal | KG + DL |
| 48 | chronic renal failure syndrome | KG + DL |
| 49 | renal osteodystrophy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.